205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.49%
Negative revenue growth while ON stands at 1.59%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
13.22%
Gross profit growth under 50% of ON's 87.85%. Michael Burry would be concerned about a severe competitive disadvantage.
597.37%
EBIT growth above 1.5x ON's 138.01%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
634.21%
Operating income growth above 1.5x ON's 133.71%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
215.38%
Net income growth above 1.5x ON's 135.03%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
233.33%
EPS growth above 1.5x ON's 135.65%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
233.33%
Diluted EPS growth above 1.5x ON's 135.65%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.46%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
3.22%
Dividend growth of 3.22% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
82.20%
Positive OCF growth while ON is negative. John Neff would see this as a clear operational advantage vs. the competitor.
146.94%
Positive FCF growth while ON is negative. John Neff would see a strong competitive edge in net cash generation.
9.50%
10Y revenue/share CAGR under 50% of ON's 71.75%. Michael Burry would suspect a lasting competitive disadvantage.
-11.69%
Negative 5Y CAGR while ON stands at 19.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-40.47%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
100.19%
5Y OCF/share CAGR above 1.5x ON's 17.99%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
6.52%
Positive 3Y OCF/share CAGR while ON is negative. John Neff might see a big short-term edge in operational efficiency.
43.07%
Below 50% of ON's 245.86%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1.45%
Below 50% of ON's 12132.26%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-45.24%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
137.33%
5Y equity/share CAGR is in line with ON's 142.72%. Walter Schloss would see parallel mid-term profitability and retention policies.
51.12%
3Y equity/share CAGR similar to ON's 54.30%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
93.58%
Dividend/share CAGR of 93.58% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
33.51%
Dividend/share CAGR of 33.51% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
2.52%
3Y dividend/share CAGR of 2.52% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.07%
Firm’s AR is declining while ON shows 12.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-19.26%
Inventory is declining while ON stands at 0.43%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.61%
Positive asset growth while ON is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.34%
BV/share growth above 1.5x ON's 0.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.15%
We’re deleveraging while ON stands at 0.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.90%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-31.95%
We cut SG&A while ON invests at 1.18%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.